Company type | Private |
---|---|
Industry | |
Founded | 1966 |
Founder | Cyrus S. Poonawalla (Chairman & MD) |
Headquarters | Pune, Maharashtra, India |
Area served | Worldwide |
Key people | Adar Poonawalla (CEO) |
Products | |
Revenue | ₹25,646 crore (US$3.1 billion) (FY22)[1] |
₹17,562 crore (US$2.1 billion) (FY22)[1] | |
₹11,116 crore (US$1.3 billion) (FY22)[1] | |
Parent | Cyrus Poonawalla Group |
Subsidiaries | Bilthoven Biologicals BV[2] Vakzine Projekt Management GmbH[3] |
Website | www |
18°30′18″N 73°56′44″E / 18.505110°N 73.945453°E Serum Institute of India (SII) is an Indian multinational biotechnology and biopharmaceuticals company, based in Pune.[4] It is the world's largest manufacturer of vaccines by volume.[5][6][7] It was founded by Cyrus Poonawalla in 1966[5] and is a part of Cyrus Poonawalla Group.[8]
cnbc
was invoked but never defined (see the help page).dw
was invoked but never defined (see the help page).